Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review

Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review

The 2019 novel coronavirus (officially known as severe acute respiratory syndrome coronavirus 2, SARS-CoV2) was first found in Wuhan, China. On February 11, 2020, the World Health Organization (WHO) has declared the outbreak of the disease caused by SARS-CoV2, named coronavirus disease 2019 (COVID-1...

Full description

Bibliographic Details
Main Authors: Saeid Safari, Alireza Salimi, Alireza Zali, Alireza Jahangirifard, Ehsan Bastanhagh, Reza Aminnejad, Ali Dabbagh, Amir Hossein Lotfi, Mohammad Saeidi
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2020-08-01
Series:Archives of Academic Emergency Medicine
Subjects:
COVID-19, cytokine storm syndrome, acute respiratory distress syndrome, hemoperfusion
Online Access:https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/860

Internet

https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/860

Similar Items